home / stock / cwbr / cwbr news

CWBR News and Press, CohBar Inc. From 03/12/20

Stock Information
Company Name: CohBar Inc.
Stock Symbol: CWBR
Market: OTC
Website: cohbar.com
Menu
CWBR CWBR Quote CWBR Short CWBR News CWBR Articles CWBR Message Board
Get CWBR Alerts

News, Short Squeeze, Breakout and More Instantly...
CWBR - CohBar to Hold Investor Meetings at the ROTH Virtual Conference

MENLO PARK, Calif., March 12, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that the company will hold its planned investor meetin...
CWBR - CohBar to Present at the 2020 BIO CEO & Investor Conference

MENLO PARK, Calif., Jan. 28, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, ...

CWBR - CohBar Appoints Jordyn Tarazi as Director of Investor Relations

MENLO PARK, Calif., Jan. 22, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat chronic diseases and extend healthy lifespan, announces the appointment of Jordyn Tarazi as Director of Invest...

CWBR - CohBar Discovers Novel Peptide Inhibitors of CXCR4, a Key Regulator of Tumor Growth and Metastasis

MENLO PARK, Calif., Jan. 08, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat chronic diseases and extend healthy lifespan, today announced the discovery of a series of novel mitochondrial...
CWBR - CLNE, TRXC, TGE and ADMS among midday movers

Gainers:  Kaixin Auto (NASDAQ: KXIN ) +32% . More news on: Kaixin Auto Holdings, NantKwest, Inc., Renewable Energy Group, Inc., Stocks on the move, Read more ...

CWBR - CohBar Confirms Anti-fibrotic Effect of a Novel Peptide in a Therapeutic Model of Idiopathic Pulmonary Fibrosis

MENLO PARK, Calif., Dec. 16, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy lifespan, today announced new preclinical data confirming the therapeu...

CWBR - CohBar's (CWBR) CEO Steve Engle on Q3 2019 Results - Earnings Call Transcript

CohBar, Inc. (CWBR) Q3 2019 Earnings Conference Call November 06, 2019 5:00 PM ET Company Participants Glen Garmont – LifeSci Advisors Jeff Biunno – Chief Financial Officer Steve Engle – Chief Executive Officer Ken Cundy – Chief Scientific Officer ...
CWBR - CohBar - The Pioneer In Mitochondrial Drugs

CohBar ( CWBR ) is a development-stage biotech company focused on drugs based on mitochondria-based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction, including non-alcoholic steatohepatitis ((NA...

CWBR - CohBar, Inc. 2019 Q3 - Results - Earnings Call Presentation

The following slide deck was published by CohBar, Inc. in conjunction with their 2019 Q3 earnings Read more ...

CWBR - CohBar Reports Third Quarter 2019 Financial Results and Business Update

MENLO PARK, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases and extend healthy lifespan, today reported its financial results for the third quarter e...
Previous 10 Next 10